ArticleBritish journal of cancer2023

Targeting metabolism by B-raf inhibitors and diclofenac restrains the viability of BRAF-mutated thyroid carcinomas with Hif-1α-mediated glycolytic phenotype.

Marianna Aprile et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.